CD11c<sup>+</sup> B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy.

In the functional study, where participants were individually matched on age and sex, we observed a nonsignificant trend toward a higher frequency of CD11c + B cells in untreated patients with RRMS.

also in 5,406 other papers